MetaTrader
  • Mercati
  • Grafici & Idee
  • Algo
  • Notizie
  • Store
  • Broker
  • Scarica
  • Calendario Economico
  • Segnali di Trading
  • Terminale Web
  • English English
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Türkçe Türkçe
Structure Therapeutics Inc. American Depositary Shares

GPCR

#725
Structure Therapeutics Inc. American Depositary Shares
62.9800
-0.54%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
62.9500
62.9800
Intervallo Annuale
26.6239
94.9000
Variazione giornaliera
-0.54%
Variazione Mensile
-29.15%
Variazione di 6 mesi
+135.53%
Variazione Annuale
+135.53%
Chiusura Precedente
63.3250
Open
62.9500
Bid
Ask
Low
62.9500
High
62.9800
Volume
46
  1. Mercati
  2. Mercato Azionario Statunitense
  3. Salute
  4. GPCR
Open full chart

Financials

Overview Estratto Conto Statistics Dividends
Quarterly Annual
Value 202320242025 TTM

Notizie

Investing Investing
NVO GPCR
ieri, 16:23
Le azioni Structure Therapeutics potrebbero salire sui dati del farmaco per l’obesità, afferma Cantor
Investing Investing
NVO SDGR GPCR
ieri, 16:22
Structure Therapeutics shares could rise on obesity drug data, Cantor says
Investing Investing
NVO SDGR GPCR
ieri, 10:20
Citizens riduce il target di prezzo di Structure Therapeutics per l’espansione della pipeline
Investing Investing
NVO SDGR GPCR
ieri, 10:19
Citizens cuts Structure Therapeutics stock price target on pipeline expansion
Zacks Zacks
NVO LLY VKTX GPCR
2026.02.25
Lilly's GLP-1 Blockbusters Drive 2025 Revenue Surge: What's Ahead?
Zacks Zacks
NVO LLY VKTX GPCR
2026.02.24
Lilly vs. Novo Nordisk: Obesity Drug Giants' Face-Off in 2026
Investor's Business Daily Investor's Business Daily
NVO LLY VKTX GPCR
2026.02.23
Novo Nordisk Dives As Next-Gen Obesity Drug Lags Eli Lilly's Kingpin
Seeking Alpha Seeking Alpha
GPCR NVO LLY VKTX PFE
2026.02.18
Structure Therapeutics: The Dark Horse Has Taken The Lead - But Is It Enough? (GPCR)
Zacks Zacks
NVO LLY VKTX GPCR
2026.02.18
Can LLY's Next-Gen Obesity Pipeline Sustain Growth Amid Competition?
Zacks Zacks
NVO LLY VKTX GPCR
2026.02.12
How to Play Eli Lilly Stock Following a Robust Q4 Earnings Report
Zacks Zacks
NVO LLY VKTX GPCR
2026.02.10
Eli Lilly's 2025 Surge Sets the Stage for Another Big Year in 2026
Investor's Business Daily Investor's Business Daily
HIMS NVO LLY VKTX GPCR
2026.02.08
Hims & Hers Health Stops Offering Knockoff Wegovy Pill Amid FDA Crackdown

Mercati

  • Mercato Azionario Americano
  • Valute
  • Criptovalute
  • Metalli
  • Materie Prime

Grafici & Idee

  • Idee di Trading
  • Idee Educative
  • Grafici

MQL5 Community

  • Market
  • Segnali
  • Forum
  • Articoli
  • CodeBase

Notizie

  • Mercato Azionario Americano
  • Valute
  • Criptovalute
  • Metalli
  • Materie Prime

Broker

  • Tutti i Broker
  • Forex
  • Azioni
  • Metalli
MetaTrader 5
MQL5 Channels
Economic Calendar
Esclusione di Responsabilità e Informativa sui Rischi Termini di Utilizzo Contatti e richieste Legale
Copyright 2000-2026, MetaQuotes Ltd